These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 26297440)

  • 1. Animal model for medication-related osteonecrosis of the jaw with precedent metabolic bone disease.
    Kim JW; Tatad JCI; Landayan MEA; Kim SJ; Kim MR
    Bone; 2015 Dec; 81():442-448. PubMed ID: 26297440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of microcracks in the pathogenesis of bisphosphonate-related osteonecrosis of the jaw.
    Kim JW; Landayan ME; Lee JY; Tatad JC; Kim SJ; Kim MR; Cha IH
    Clin Oral Investig; 2016 Nov; 20(8):2251-2258. PubMed ID: 26795624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomarkers for Bisphosphonate-Related Osteonecrosis of the Jaw.
    Kim JW; Cha IH; Kim SJ; Kim MR
    Clin Implant Dent Relat Res; 2016 Apr; 18(2):281-91. PubMed ID: 25726720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Teriparatide and the treatment of bisphosphonate-related osteonecrosis of the jaw: a rat model.
    Ersan N; van Ruijven LJ; Bronckers AL; Olgaç V; Ilgüy D; Everts V
    Dentomaxillofac Radiol; 2014; 43(1):20130144. PubMed ID: 24170800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zoledronic acid - related osteonecrosis of the jaws. Experimental model with dental extractions in rats.
    Barba-Recreo P; Del Castillo Pardo de Vera JL; García-Arranz M; Yébenes L; Burgueño M
    J Craniomaxillofac Surg; 2014 Sep; 42(6):744-50. PubMed ID: 24342733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of pH alteration on the pathogenesis of medication-related osteonecrosis of the jaw.
    Kim JW; Alfafara AMD; Kim HY; Kim SY; Kim SJ
    Bone; 2019 May; 122():45-51. PubMed ID: 30738857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Periapical disease and bisphosphonates induce osteonecrosis of the jaws in mice.
    Kang B; Cheong S; Chaichanasakul T; Bezouglaia O; Atti E; Dry SM; Pirih FQ; Aghaloo TL; Tetradis S
    J Bone Miner Res; 2013 Jul; 28(7):1631-40. PubMed ID: 23426919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of BP-ONJ in osteopenic and healthy sheep: comparing ZTE-MRI with µCT.
    Voss P; Ludwig U; Poxleitner P; Bergmaier V; El-Shafi N; von Elverfeldt D; Stadelmann V; Hövener JB; Flügge T
    Dentomaxillofac Radiol; 2016; 45(4):20150250. PubMed ID: 26846710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. OPG-Fc but Not Zoledronic Acid Discontinuation Reverses Osteonecrosis of the Jaws (ONJ) in Mice.
    de Molon RS; Shimamoto H; Bezouglaia O; Pirih FQ; Dry SM; Kostenuik P; Boyce RW; Dwyer D; Aghaloo TL; Tetradis S
    J Bone Miner Res; 2015 Sep; 30(9):1627-40. PubMed ID: 25727550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histopathological Effects of Teriparatide in Medication-Related Osteonecrosis of the Jaw: An Animal Study.
    Keskinruzgar A; Bozdag Z; Aras MH; Demir T; Yolcu U; Cetiner S
    J Oral Maxillofac Surg; 2016 Jan; 74(1):68-78. PubMed ID: 26215490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteonecrosis of the Jaw Developed in Mice: DISEASE VARIANTS REGULATED BY γδ T CELLS IN ORAL MUCOSAL BARRIER IMMUNITY.
    Park S; Kanayama K; Kaur K; Tseng HC; Banankhah S; Quje DT; Sayre JW; Jewett A; Nishimura I
    J Biol Chem; 2015 Jul; 290(28):17349-66. PubMed ID: 26013832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapeutic and antiresorptive combination therapy suppressed lymphangiogenesis and induced osteonecrosis of the jaw-like lesions in mice.
    Kuroshima S; Yamashita J
    Bone; 2013 Sep; 56(1):101-9. PubMed ID: 23727433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zoledronate induces bisphosphonate-related osteonecrosis of the jaw in osteopenic sheep.
    Voss PJ; Stoddart MJ; Bernstein A; Schmelzeisen R; Nelson K; Stadelmann V; Ziebart T; Poxleitner PJ
    Clin Oral Investig; 2016 Jan; 20(1):31-8. PubMed ID: 25843053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased prevalence of bisphosphonate-related osteonecrosis of the jaw with vitamin D deficiency in rats.
    Hokugo A; Christensen R; Chung EM; Sung EC; Felsenfeld AL; Sayre JW; Garrett N; Adams JS; Nishimura I
    J Bone Miner Res; 2010 Jun; 25(6):1337-49. PubMed ID: 20200938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiresorptive Agent-Related Osteonecrosis of the Jaw (ARONJ): A Twist of Fate in the Bone.
    Shibahara T
    Tohoku J Exp Med; 2019 Feb; 247(2):75-86. PubMed ID: 30713280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dental extraction following zoledronate, induces osteonecrosis in rat's jaw.
    Vidal-Gutiérrez X; Gómez-Clavel JF; Gaitán-Cepeda LA
    Med Oral Patol Oral Cir Bucal; 2017 Mar; 22(2):e177-e184. PubMed ID: 28160593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of periodontal disease in bisphosphonate-related osteonecrosis of the jaws in ovariectomized rats.
    Li CL; Lu WW; Seneviratne CJ; Leung WK; Zwahlen RA; Zheng LW
    Clin Oral Implants Res; 2016 Jan; 27(1):1-6. PubMed ID: 25371026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.
    Pazianas M; Miller P; Blumentals WA; Bernal M; Kothawala P
    Clin Ther; 2007 Aug; 29(8):1548-58. PubMed ID: 17919538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of osteonecrosis of the jaw in patients with bone metastases treated with bisphosphonates.
    DE Iuliis F; Taglieri L; Amoroso L; Vendittozzi S; Blasi L; Salerno G; Lanza R; Scarpa S
    Anticancer Res; 2014 May; 34(5):2477-80. PubMed ID: 24778063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered microRNA expression profile in the peripheral lymphoid compartment of multiple myeloma patients with bisphosphonate-induced osteonecrosis of the jaw.
    Musolino C; Oteri G; Allegra A; Mania M; D'Ascola A; Avenoso A; Innao V; Allegra AG; Campo S
    Ann Hematol; 2018 Jul; 97(7):1259-1269. PubMed ID: 29546453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.